BODY FLUIDS;
DRUG PRODUCTS;
ELECTROSPRAY IONIZATION;
EMERGENCY ROOMS;
EXTRACTION;
MASS SPECTROMETRY;
PHASE SEPARATION;
25I-NBOME;
2CC-NBOME;
DESINGER DRUG;
DRUG OF ABUSE;
EMERGENCY DEPARTMENTS;
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
HPLC-MS-MS;
HUMAN SERUM;
PHENETHYLAMINES;
SCIENTIFIC LITERATURE;
ARTICLE;
CHROMATOGRAPHY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
ELECTROSPRAY;
EMERGENCY WARD;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LIMIT OF DETECTION;
LIMIT OF QUANTITATION;
LIQUID LIQUID EXTRACTION;
MASS SPECTROMETRY;
QUADRUPOLE MASS SPECTROMETRY;
QUALITY CONTROL;
SOLID PHASE EXTRACTION;
TANDEM MASS SPECTROMETRY;
25I-NBOME;
2CC-NBOME;
DESINGER DRUGS;
HPLC/MS/MS;
CALIBRATION;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DESIGNER DRUGS;
DRUG STABILITY;
HUMANS;
LIMIT OF DETECTION;
PHENETHYLAMINES;
REPRODUCIBILITY OF RESULTS;
SOLID PHASE EXTRACTION;
TANDEM MASS SPECTROMETRY;
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers
doi: 10.1007/s00259-010-1686-8
Ettrup A, Hansen M, Santoni MA, Paine J, Gillings N, Palner M, Lehel S, Herth MM, Madsen J, Kristensen J, Begtrup M and Knudsen GM. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers. European Journal of Nuclear Medicine and Molecular Imaging 2011; 38: 681-693; doi: 10.1007/s00259-010-1686-8
'Legal highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist
doi: 10.3109/15563650.2011.645952
Gibbons S. 'Legal highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clinical Toxicology 2012; 50: 15-24; doi: 10.3109/15563650.2011.645952
Case series of 25I-NBOMe exposures with laboratory confirmation. [Abstract]
Kelly A, Eisenga B, Riley B and Judge B. Case series of 25I-NBOMe exposures with laboratory confirmation. [Abstract] Clinical Toxicology 2012; 50: 702.
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4 iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand
doi: 10.1016/j.bmc.2008.04.050.
Nichols DE, Frescasa SP, Chemela BR, Rehderb KS, Zhongb D and Lewin AH. High specific activity tritium-labeled N-(2-methoxybenzyl)-2, 5-dimethoxy-4 iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand. Bioorganic and Medincinal Chemistry 2008; 16: 6116-6123. doi: 10.1016/j.bmc.2008.04.050.
Severe poisoning following self reported use of 25-I, a novel substituted amphetamine. [Abstract]
Rose SR, Cumpston KL, Stromberg PE and Wills BK. Severe poisoning following self reported use of 25-I, a novel substituted amphetamine. [Abstract] Clinical Toxicology 2012; 50: 707-708.
A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug
doi: 10.3109/15563650.2013.772191
Rose SR, Poklis JL and Poklis A. A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clinical Toxicology 2013; 51: 174-177; doi: 10.3109/15563650.2013.772191
US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001.
Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-B-phenethylamine (2C-G) - a new designer drug
doi: 10.1002/dta.1396
Zuba D and Sekula K. Identification and characterization of 2, 5-dimethoxy-3, 4-dimethyl-B-phenethylamine (2C-G) - a new designer drug. Drug Testing and Analysis 2013A; 5: 549-59; doi: 10.1002/dta.1396
25C-NBOMe - new potent hallucinogenic substance identified on the drug market
doi: 10.1016/j.forsciint.2012.08.027
Zuba D, Sekula K and Buczek A. 25C-NBOMe - new potent hallucinogenic substance identified on the drug market. Forensic Science International 2013B; 227: 7-14; doi: 10.1016/j.forsciint.2012.08.027
